Insomnia CBT-I Success: 80% See Improvement | Ned Tijdschr

80% of Patients See Clinically Relevant Improvement With First-Line Insomnia Treatment

Chronic insomnia disorder burdens an estimated 10-15% of adults. It increases the risk for depression, cardiovascular disease, and diminished quality of life. The Dutch medical journal Ned Tijdschr Geneeskd published a 2026 review stating that Cognitive Behavioral Therapy for Insomnia (CBT-I) achieves strong, long-lasting effects for up to 80% of patients. This behavioral treatment is now the recommended first-line intervention, supported by the American Academy of Sleep Medicine (AASM). Medication like temazepam, while useful for short-term crisis management, is not a sustainable solution and carries risks of tolerance and dependency.

Wider clinical adoption faces hurdles. Researchers Rauwerda and Bakker note that limited awareness, practitioner access, and inconsistent insurance reimbursement hinder implementation, despite the robust evidence base. This guide details what CBT-I is, how it works, and why it represents a fundamental shift in managing chronic sleep problems.

CBT-I Targets the Factors That Perpetuate Sleeplessness

Insomnia often begins with a stressor—a period of grief, work pressure, or illness. For many, sleep normalizes once the stressor passes. For others, it becomes chronic. CBT-I operates on a core principle: the original cause of sleeplessness is often less important than the behaviors and thoughts that maintain it over months or years. The therapy directly addresses these perpetuating factors.

Sleep Restriction Builds Robust Sleep Drive

One of the most effective behavioral components is sleep restriction. A patient who spends 9 hours in bed but sleeps only 6 hours has a sleep efficiency of 67%. This creates a link between the bed and wakefulness. A therapist calculates the patient’s average total sleep time and initially restricts time in bed to that number, often with a minimum of 5-6 hours. This builds a stronger homeostatic sleep drive. As efficiency improves, time in bed is gradually increased. This technique counters the instinct to “try harder” by spending more time in bed, which actually fragments sleep further.

Cognitive Restructuring Addresses Anxiety and Beliefs

Thoughts like “I’ll be worthless tomorrow if I don’t sleep tonight” or “My health is crumbling” create performance anxiety around sleep. This anxiety activates the sympathetic nervous system, directly opposing the relaxation needed for sleep onset. CBT-I uses cognitive restructuring to identify, challenge, and modify these unrealistic beliefs. Patients learn to replace catastrophic thinking with more balanced statements, reducing the emotional charge around the bed.

Stimulus Control Reassociates the Bed with Sleep

The stimulus control protocol is clear: the bed is only for sleep and sex. If awake for more than 20 minutes, patients are instructed to get up, go to another room, and engage in a quiet, non-stimulating activity until feeling sleepy. This breaks the cycle of frustration and reassociates the bedroom environment with rapid sleep onset, rather than with wakeful rumination.

Sleep Hygiene and Relaxation Provide a Foundation

While not sufficient on their own to treat chronic insomnia, education on sleep hygiene (managing light, caffeine, and routine) and training in relaxation techniques (diaphragmatic breathing, progressive muscle relaxation) provide a necessary foundation. They remove common barriers and give patients tools to quiet the mind and body.

New AASM Guidelines Endorse Starting CBT-I and Medication Together

For decades, a debate persisted: should patients use medication or therapy? The AASM’s 2026 clinical practice guideline, authored by a panel including Dr. Daniel Buysse of the University of Pittsburgh, provides a clear answer for many adults. The guideline recommends combination treatment—starting CBT-I concurrently with prescribed pharmacotherapy.

This approach acknowledges the immediate relief medication can provide while the slower, skill-building process of CBT-I takes effect. The therapy then provides a durable framework for sleep health, often allowing for medication reduction or discontinuation. The Dutch case study highlighted this integrated model, showing CBT-I’s role in supporting structured medication tapering. You can read the full analysis of this guideline in our article, AASM 2026 Guideline: CBT-I and Medication for Insomnia.

A limitation of combination therapy is the need for careful coordination between prescribing physicians and behavioral sleep specialists, which can be logistically challenging.

CBT-I Produces More Sustainable Outcomes Than Sleep Medication

The evidence comparing CBT-I to pharmacotherapy is consistent. Medications like zolpidem (Ambien) or eszopiclone (Lunesta) work quickly but their effects often diminish with regular use, leading to dose escalation. Side effects like daytime drowsiness, complex sleep behaviors, and risk of dependency are well-documented. The Dutch review advises these drugs be used for no longer than 2-4 weeks.

CBT-I requires more effort initially. Treatment typically spans 6-8 weekly sessions. However, its effects endure. Studies show benefits persist for years after treatment ends because patients internalize skills and change their relationship with sleep. As noted in the review, this supports long-term patient autonomy. Research also confirms CBT-I is effective even for individuals with comorbid conditions like depression, chronic pain, or cancer, whereas sedative medications can sometimes worsen these conditions. For more on long-term outcomes, see CBT-I Therapy Success: 4-Year Study Results.

How to Access and Implement Evidence-Based CBT-I

Finding qualified treatment is the critical next step. Several validated delivery formats exist beyond traditional in-person therapy.

Work With a Certified Behavioral Sleep Medicine Specialist

The gold standard is working one-on-one with a provider certified in Behavioral Sleep Medicine (BSM). These are typically psychologists, psychiatrists, or other clinicians with advanced training. They can tailor protocols to individual complexities, such as shift work or comorbid PTSD. The Society of Behavioral Sleep Medicine (SBSM) and AASM maintain provider directories.

Consider Digital Therapeutics and Guided Programs

For those with geographical or scheduling barriers, digital CBT-I programs offer a proven alternative. FDA-cleared digital therapeutics like Somryst deliver a standardized, interactive program with automated guidance. Many hospital systems and employers offer access to these platforms. Research on mobile app-based CBT-I, such as the study showing improvements sustained over four years, supports their efficacy for many individuals.

Prepare for the Process

Effective CBT-I demands active participation. Patients should prepare to:

• Keep a detailed sleep diary for at least two weeks before starting.
• Commit to the prescribed sleep-wake schedule, even on weekends.
• Practice cognitive and relaxation exercises daily.
• Tolerate initial sleep restriction, which may temporarily increase daytime sleepiness before improving sleep consolidation.

It is not a passive “cure” but an active skill acquisition process.

Key Takeaways

• CBT-I is the recommended first-line treatment for chronic insomnia. Major medical bodies endorse it due to strong evidence for efficacy and durability.
• It works for up to 80% of patients by targeting the behavioral and cognitive factors that maintain insomnia, not just its symptoms.
• New 2026 guidelines support starting CBT-I and sleep medication together. This combination can provide immediate relief while building long-term skills, as detailed in the AASM guideline analysis.
• Effects last longer than those of sleep medications. Patients maintain gains for years after therapy ends, whereas medication benefits often wane and carry greater side-effect risks.
• Access is improving through digital therapeutics and specialist directories. While barriers remain, online programs and certified providers make treatment more available than ever.
• Success requires consistent practice of new skills. Patients should expect to complete daily sleep diaries and adhere to sleep schedules for 6-8 weeks.

This article is for informational purposes only. Consult a qualified professional for personalised advice.

Sources:
https://pubmed.ncbi.nlm.nih.gov/41989125/
https://pubmed.ncbi.nlm.nih.gov/41975142/